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Epidermoid tumors (ETs) are benign rare, 
slow-growing lesions that account for roughly 0.2 
to 1.8% of all intracranial tumors [1]. They have 
been described as “pearly” and “the most beautiful 
tumors in the body” [2]. This pearly appearance 
comes from their keratin and fatty acid contents and 
stratified epithelium lining [3]. It is believed they 
derive from the neural tube entrapping ectodermal 
cells during closure between the 3rd and 5th weeks 
of embryonic development [4]. They are most com-
monly located in the cerebellopontine angle (CPA), 
accounting for 40% of epidermoid tumor cases 
and tend to accumulate around vital neurovascular 
structures causing trigeminal neuralgia and hemifa-
cial spasms to be common symptoms [1, 5].
Total resection is a common neurosurgical rec-
ommendation of these tumors; nonetheless, it is 
difficult to do so while preserving the neurovascu-
AbstrAct
background: epidermoid tumors (eTs) of the central nervous system (cNs) are rare tumors that typically occur in the 4th dec-
ade. They typically grow around vital neurovascular structures which makes surgical treatment difficult. The objective of this 
paper is to report on the effectiveness and safety in the management of epidermoid tumors with gamma knife surgery (GKs).
Materials and methods: This is a retrospective study of the medical records of 8 patients treated with GKs for epidermoid 
tumors between July 2010 to June 2019. The median prescription dose was 11 Gy, ranging from 10 to 12 Gy, 5 patients received 
the total dose target to the 50% line and 3 to the 55% isodose line. The mean tumor volume was 12.4 cc ranging from 4.4 to 
24.8cc. The median follow-up time was 33.7 months and ranged from 0.9 to 58.8 months. at follow-up, patients were evalu-
ated for neurological signs and symptoms and radiographic evidence of progression of disease. Two patients were treated 
after failure of linac stereotactic radiosurgery. One patient underwent stereotactic radiosurgery prior to GKs, and the other 
had failed surgical resection prior to GKs.
results: The median age was 33 years old. There were two males and six females. The most common presenting manifestation 
was headaches followed by vision and hearing problems. symptoms were resolved in all cases, except for one who had partial 
control of trigeminal neuralgia. all patients were locally controlled by imaging and neurological examination at first follow-up.
conclusion: Gamma knife surgery is a safe and effective alternative treatment in patients with cNs epidermoid tumors and 
should be included in the initial recommendation. 
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lar structures it surrounds [2]. This makes partial 
resection necessary to preserve neurological func-
tion. However, partial removal of these tumors typi-
cally leads to recurrence and thus reoperation [3]. 
GKS may be the preferred alternative therapy. There 
have been very few studies reporting on the treat-
ment of epidermoid tumors with GKS [4-6]. This 
study aims to offer insight into the effectiveness and 
safety of treating epidermoid tumors with gamma 
knife surgery, compared to surgical intervention, 
and provide distinct reasons why this may be a fa-
vored treatment option.
Materials and methods
This is a retrospective study of eight patients (two 
males and six females, ages ranging from 22 to 56 
with a median age of 33) who were treated with GKS 
for epidermoid tumors from July 2010 to June 2018 
at the Miami Neuroscience Center. One patient re-
ceived a craniotomy, and another received stereotac-
tic radiosurgery before GKS while the other six have 
only undergone GKS. Patients were diagnosed preop-
eratively with computed tomography (CT) scans and 
magnetic resonance imaging (MRI) of the brain. Pre-
senting symptoms were recorded at the initial visit.
The Leksell Gamma Knife stereotactic frame was 
placed on each patient’s head using lidocaine as 
local anesthesia after appropriate premedication 
with 1 g of cefazolin and 20 mg of dexamethasone 
and intravenous sedation with propofol and mid-
azolam. Imaging was based on MRI stereotactic 
localization of the lesion, visualization and volume 
dosimetry mapping. Radiosurgical treatment plan-
ning was done in conjugation with the radiation 
oncologist and the radiation physicist using gamma 
plan. The treatment plan consisted of an average of 
22.4 isocenter. Treatment was carried out using the 
Perfexion Gamma Knife with a mean treatment 
time of 122 minutes (ranging from 48 minutes to 
191 minutes). The median prescription dose was 
11 Gy, ranging from 10 to 12 Gy, and five patients 
received the total dose target to the 50% and three 
to the 55% isodose line. The mean tumor volume 
was 12.4 cc ranging from 4.4 to 24.8cc.
The median clinical follow-up time was 33.7 
months and ranged from 0.9 to 58.8 months. Pa-
tients follow-ups occurred in-person, except for one 
patient that followed up over the phone, and con-
sisted of brain surveillance MRI imaging and clini-
cal neurological evaluation after 1 month then in 
3-months and then every 6 months or if there were 
new or worsening symptoms. At follow-ups, pa-
tients were evaluated for neurological and radiologi-
cal progression of the disease.Clinical status was as-
sessed by a complete neurological exam and patient 
history while radiographic status was determined by 
measuring tumor volume in cubic centimeters via 
MRI imaging. Neurological and radiographic pro-
gression was then determined to be stable, improved 
or worsened based on the change in pretreatment 
to post-treatment status. Radiographic progression 
was defined as an increase in tumor volume and tu-
mor control was defined as unchanged or decreased 
tumor volume. Symptom control was defined as 
stable or improved symptoms. 
results
The median age was 33 years old with two males 
and six females. Follow-up growth was recorded for 
all patients except one due to being lost to follow 
up. The most common tumor location was the cer-
ebellopontine angle (6/8), with one extending from 
the prepontine cistern to the interpeduncular fossa 
and another extending to the left prepontine cistern 
(Tab. 1). There was one temporal fossa lesion and 
one posterior fossa lesion that extended from the 
foramen magnum to the prepontine cistern. Most 
of the lesions were on the left side (5/8; Tab. 1). Six 
patients presented headaches, making it the most 
common symptom (Fig. 1). Three patients present-
ed vision difficulties (loss, diplopia, vision changes) 
and three patients presented hearing difficulties, 
including hearing loss and tinnitus. Two patients 
presented trigeminal neuralgia. while four patients 
experienced pain in other parts of their body, in-
cluding the neck, back, and shoulder (Tab. 1). Some 
patients used medicine (paracetamol or ibuprofen) 
to relieve their pain but with only partial control. 
Accompanying symptoms included nausea, dizzi-
ness, lack of balance, fatigue, and tingling sensation 
in the face and head in five patients.
None of the patients developed side-effects af-
ter GKS. Of the six patients presenting with head-
aches, none reported headaches one month after 
the procedure. Three of the six developed recurrent 
headaches, one for seven months with partial local 
control, and the other 2 at 31 and 16 months until 
headaches were fully resolved.
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One of the patients that presented with tri-
geminal neuralgia was only partially controlled 49 
months after GKS. Another had recurring trigemi-
nal neuralgia post GKS and was partially controlled 
by medications (carbamazepine), requiring a sec-
ond GKS to the trigeminal nerve that resolved it af-
ter 18 months. Vision problems were resolved with 
all patients within one-month post GKS. Hearing 
problems were resolved in all cases. In one case, vi-
sion was resolved within a month and for the other 
two cases, the follow-up time was not recorded. All 
patients had tumor control or shrinkage (Tab. 2). 
One patient, in particular, experienced great reduc-
tion in tumor size, post GKS (Fig. 2). All accompa-
nying symptoms were resolved in all patients. 
Discussion
ET are benign unusual tumors that respond well 
and relatively fast to radiosurgery.  In this retro-
spective study, GKS locally controls ET in all our 
cases with a median follow-up of 3 months.
Our results are consistent with data of prior ET 
GKS studies, including Vasquez et al., El-Shehaby 
et al., and Kida et al., with three, 12, and seven 
patients, respectively [4, 6]. These studies observed 
patients as asymptomatic until about the fourth 
decade, consistent with our study showing an av-
erage age at the treatment of 35 years. Common 
symptoms have been reported to be headaches, tri-
geminal neuralgia, vision and hearing difficulties 
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Figure 1. The most common presenting symptoms
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and seizures [4-5,7]. Unlike these other studies, 
our study does not have many patients reporting 
trigeminal neuralgia (2/8) or seizures (0/8).
Vasquez et al., El-Shehaby et al., and Kida et al. 
used a median prescription dose of 12 Gy, 11 Gy, 
and mean of 14.6 Gy respectively. These studies re-
ported complete relief or improvement in almost all 
patients. Except for El-Shehaby et al., who reported 
trigeminal pain uncontrolled in two patients and 
partially controlled in one [5]. Similarly, our study 
had one of the trigeminal patients with partially 
controlled pain. Furthermore, all studies reported 
tumor control in all cases. These other studies re-
ported a similar average follow-up time of 10, 38, 
and 53 months, respectively, compared to our 33.14 
months [4–6].
Many have published on the success of surgical 
resection of ETs, including Lynch et al., De Souza 
et al., Kato et al. and Chowdhury et al.; however, 
there is a debate on the best approach (Tab. 3) [2, 
7–9]. Many studies argue total removal is the best 
approach because it is believed to prevent recur-
table 2. Treatment outcomes
Patient Presenting symptoms Growth Follow up (months)
1 headaches, blurred vision No 0.9
2 headaches, tinnitus, vision changes No 27.3
3 Tinnitus, balance issues, tingling in face No 52.4
4 headaches, hearing loss No 11.8
5 headaches No 31.2
6 headaches No 58.8
7 Trigeminal neuralgia, vision problems No 36.1
8 headaches, trigeminal neuralgia No 38.9











Lynch et al. 2014 33 0 42.42 72.7 9 86.4
De souza et al. 1989 30 3.7 40 18 14.8 108
Kato et al. 2013 27 5 33.33 10 20 N/a
chowdhury et al. 2013 23 4.3 13.04 73.9 N/a 36
Overall 113 3.25 32.29 43.65 14.6 76.8
GTr — gross tumor removal; N/a — non available
Figure 2. A. pre-Gamma Knife MrI of patient 3 with a 13.7cc epidermoid tumor treated with 10Gy; b. post-Gamma Knife MrI 
of patient 3 52.4 months showing tumor shrinkage
a
B
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rence [2, 7, 9]. However, difficulties arise due to Ets’ 
proximity to the nerves and vascular structures [1, 
2]. Partial removal appears to be a better option, but 
this could lead to recurrence. Therefore, GKS may 
be a more effective treatment.
While comparing cases of GKS and surgical 
treatment, GKS appears to be a better alternative 
when total removal does not seem possible or if 
there is a recurrence. GKS is a better alternative 
because it leads to a quicker recovery. The surgical 
treatment cases had an average follow-up time of 
76.8 months (Tab. 3), while in the GKS studies, the 
average follow-up time was 33.53 months [2, 4–9]. 
GKS also has less recurrence, with only two out of 
the 30 cases (6.67%) of the previously mentioned 
GKS studies and this one included, showing recur-
rent symptoms or tumor growth. While the surgi-
cal studies have a recurrence of 14.6%. Further-
more, these studies report much higher morbidity 
of 32.29%, while the previously mentioned GKS 
studies report lower morbidity (13.33%) [2, 4–9].
Surgical removal could lead to permanent neu-
rological deficits considering Ets’ proximity to and 
encasement of vital structures, thereby making GKS 
a safer option [1, 2]. Other papers report a low mor-
tality rate of surgical intervention of ETs, but GKS 
still leads to lower mortality. In the previously men-
tioned studies, surgical intervention has a mortality 
rate of 3.25% compared to GKS having a mortality 
rate of 0% (Tab. 3). We hope that this data encourag-
es patients to look at GKS as an option when surgery 
is not preferred or there is recurrent tumor growth.
There are limitations in this case series due to 
its retrospective nature and relatively small sample 
size. We recognize it is difficult to make recommen-
dations for clinical practice due to the lack of a ref-
erence group. Prospective studies comparing GKS 
to another treatment method should be employed 
to make a more definitive recommendation on the 
use of GKRS but would be unlikely due to the low 
incidence of glomus jugulare tumors. 
conclusion
This data confirms that GKS is an effective treat-
ment for ET and a viable alternative to surgical 
intervention.  GKS can be offered as an upfront 
alternative treatment of ET in unresectable patients 
or patients with high surgical risk as local control is 
maintained and the morbidity remains low or nil. 
Although the numbers of this series is small and 
the follow-up is short, the results are encouraging. 
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